ORASURE TECHNOLOGIES, INC Current Liabilities
ORASURE TECHNOLOGIES, INC (OSUR) had Current Liabilities of $25.12 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Liabilities, Current $25.12M.
- 2026-03-31: Liabilities, Current $44.08M.
- 2025-12-31: Liabilities, Current $39.80M.
- 2025-09-30: Liabilities, Current $40.25M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $25.12M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $44.08M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $39.80M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $40.25M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $42.35M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $25.42M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $33.48M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $27.78M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $28.85M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $29.11M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $39.54M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $40.95M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $46.42M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $55.12M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $69.06M 10-K · filed 2024-03-11 | $70.39M 10-K · filed 2023-03-03 |
| 2022-09-30 | $71.70M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $65.49M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $55.59M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $68.06M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $54.17M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $46.57M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $44.64M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $46.49M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $37.23M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $30.59M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $26.34M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $32.71M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $28.94M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $29.95M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $27.31M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $27.98M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $21.42M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $21.12M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $21.19M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $32.24M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $26.62M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $23.19M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $18.28M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $17.34M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $21.95M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $26.07M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $20.34M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $25.23M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $29.70M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $15.60M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $17.53M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $26.46M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $25.25M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $14.71M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $14.97M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $18.98M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $19.33M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $15.98M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $17.99M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $16.63M 10-K · filed 2014-03-14 | $16.92M 10-K · filed 2013-03-13 |
| 2012-09-30 | $17.00M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $20.80M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $19.13M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $21.98M 10-K · filed 2013-03-13 | $21.98M 10-K · filed 2012-03-14 |
| 2011-09-30 | $20.30M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $20.05M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $19.68M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |